Skip to Main Content

Paper Details

A distinct p53 target gene set predicts for response to the selective p53-HDM2 inhibitor NVP-CGM097.
Elife
61
2015
13, HDM2, NVP, NVP-CGM097, anti, cancer, cell line, cell lines, p53, p53 downstream target genes, p53 target gene set, patient, patients, predictive gene signature, tumor, tumors, up-regulated genes, wild, wild-type p53
Author NameAffiliation
Stephane FerrettiNovartis Institutes for BioMedical Research
Hans BitterNovartis Institutes for BioMedical Research
William R SellersNovartis Institutes for BioMedical Research
  • 1 - 3

Datasets

Release 1.2